Physician
Koymen, Altug
Koymen, Altug was paid $1.23M by Medicaid between Feb 2018 and Dec 2024, across 52 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 11% of everything it billed.
33Billing provider infoKOYMEN, ALTUG
PROVIDENCE, RI 02908
PROVIDENCE, RI 02908
33aNPI1336170893assigned 07/05/2006
33bProvider typeObstetrics & Gynecology Physician
28Total paid$1.23M
24GClaims23,912
24DCodes billed52
24AFirst – last monthFeb 2018 – Dec 2024
Compared with peers
Next to other Obstetrics & Gynecology Physician providers in Rhode Island
Rank by total paid#3 of 106
Median peer was paid$8K
This provider vs. median149×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,217 | $87K | |
| 2019 | 153 | $5K | |
| 2020 | 2,599 | $135K | |
| 2021 | 5,267 | $266K | |
| 2022 | 4,193 | $210K | |
| 2023 | 5,761 | $345K | |
| 2024incomplete | 3,722 | $186K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 11% | 3,288 | 2,962 | $142K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 9.4% | 799 | 742 | $116K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 6.8% | 799 | 742 | $84K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 6.6% | 1,264 | 1,234 | $82K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 5.9% | 757 | 644 | $73K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 5.4% | 736 | 722 | $67K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 5.3% | 860 | 821 | $66K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5.3% | 1,561 | 1,449 | $66K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 5.3% | 1,203 | 1,171 | $66K |
| 86780 | 3.8% | 854 | 814 | $46K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.4% | 1,410 | 1,263 | $42K |
| 86850 | 2.9% | 464 | 443 | $36K |
40 more codes
| 86901 | 2.3% | 463 | $28K | |
| 86900 | 2.3% | 463 | $28K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.7% | 1,531 | $21K |
| 76801 | 1.5% | 418 | $19K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 1.5% | 369 | $18K |
| 86481 | 1.5% | 127 | $18K | |
| 86803 | 1.3% | 133 | $17K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 1.3% | 361 | $16K |
| 86762 | 1.2% | 133 | $15K | |
| 86787 | 1.1% | 122 | $14K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.1% | 142 | $13K |
| T1015 | A visit at a community health center or clinic (one all-in rate) | 1.1% | 102 | $13K |
| 87340 | 1.0% | 134 | $13K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 40 | $11K |
| 59025 | Fetal non-stress test | <1% | 317 | $11K |
| 81001 | <1% | 148 | $10K | |
| 81025 | <1% | 2,140 | $10K | |
| 76830 | Ultrasound, transvaginal | <1% | 26 | $8K |
| 59426 | <1% | 12 | $8K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 26 | $7K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 95 | $6K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 302 | $6K |
| S0612 | Annual gynecological examination, established patient | <1% | 98 | $6K |
| 82950 | <1% | 85 | $3K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 362 | $3K |
| 82105 | <1% | 54 | $3K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 52 | $3K |
| 87210 | <1% | 810 | $3K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 44 | $3K |
| 87150 | <1% | 24 | $2K | |
| 83020 | <1% | 12 | $2K | |
| 86480 | <1% | 12 | $2K | |
| 99401 | <1% | 55 | $2K | |
| 59430 | <1% | 13 | $1K | |
| 81002 | <1% | 625 | $1K | |
| 84702 | <1% | 17 | $1K | |
| 82677 | <1% | 13 | $1K | |
| 83021 | <1% | 12 | $959.22 | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 12 | $684.80 |
| 86336 | <1% | 13 | $371.21 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.